The stock highlighted in today’s article may not be anywhere near as well-known as its large, diversified rivals, but it is outperforming all of them – and, as such, it may be worth getting to know! The stock in question is Exactech, an orthopedic-device stock that “is the best-performing stock in the orthopedic products sector this year”, beating giants such as Johnson & Johnson and Smith & Nephew. (Exactech has gained 53% so far this year; its rivals have only gained an average of 14%). How has Exactech achieved these gains with little exposure and limited resources, and how is it positioned to continue this momentum going forward? CLICK HERE to find out.